Zanoterone is an orally active antagonist of the androgen receptor (AR) with a Ki of 2.2 µM. Zanoterone blocks the binding of androgens such as testosterone and dihydrotestosterone (DHT), inhibiting the androgen signaling pathway, thereby reducing androgen-dependent prostate hyperplasia and prostate cancer growth[1].
Molecular Weight:
416.58
CAS Number:
[107000-34-0]
Formula:
C23H32N2O3S
Target:
Androgen Receptor
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
